These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16051411)

  • 1. Diagnostic aspects of organophosphate poisoning.
    Worek F; Koller M; Thiermann H; Szinicz L
    Toxicology; 2005 Oct; 214(3):182-9. PubMed ID: 16051411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
    Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
    Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
    Bartling A; Worek F; Szinicz L; Thiermann H
    Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of methods used for the determination of cholinesterase activity in whole blood.
    Naik RS; Doctor BP; Saxena A
    Chem Biol Interact; 2008 Sep; 175(1-3):298-302. PubMed ID: 18555980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of red blood cell acetylcholinesterase by oral huperzine A against ex vivo soman exposure: next generation prophylaxis and sequestering of acetylcholinesterase over butyrylcholinesterase.
    Haigh JR; Johnston SR; Peppernay A; Mattern PJ; Garcia GE; Doctor BP; Gordon RK; Aisen PS
    Chem Biol Interact; 2008 Sep; 175(1-3):380-6. PubMed ID: 18572153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State-wide hospital clinical laboratory plan for measuring cholinesterase activity for individuals suspected of exposure to nerve agent chemical weapons.
    Wu AH; Smith A; McComb R; Bowers GN; Makowski GS; McKay CA; Vena J; McDonagh J; Hopfer S; Sena SF; Malkus H; Forte E; Kelly K
    Clin Toxicol (Phila); 2008 Feb; 46(2):110-6. PubMed ID: 17952751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advantages of the WRAIR whole blood cholinesterase assay: comparative analysis to the micro-Ellman, Test-mate ChE, and Michel (DeltapH) assays.
    Haigh JR; Lefkowitz LJ; Capacio BR; Doctor BP; Gordon RK
    Chem Biol Interact; 2008 Sep; 175(1-3):417-20. PubMed ID: 18555983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
    Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
    Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of human serum butyrylcholinesterase against sarin vapor.
    Saxena A; Sun W; Dabisch PA; Hulet SW; Hastings NB; Jakubowski EM; Mioduszewski RJ; Doctor BP
    Chem Biol Interact; 2008 Sep; 175(1-3):267-72. PubMed ID: 18597747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone acetylase inhibitor trichostatin A induces acetylcholinesterase expression and protects against organophosphate exposure.
    Curtin BF; Tetz LM; Compton JR; Doctor BP; Gordon RK; Nambiar MP
    J Cell Biochem; 2005 Nov; 96(4):839-49. PubMed ID: 16149071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.
    Li B; Sedlacek M; Manoharan I; Boopathy R; Duysen EG; Masson P; Lockridge O
    Biochem Pharmacol; 2005 Nov; 70(11):1673-84. PubMed ID: 16213467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning.
    Lucić Vrdoljak A; Calić M; Radić B; Berend S; Jun D; Kuca K; Kovarik Z
    Toxicology; 2006 Nov; 228(1):41-50. PubMed ID: 16982122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotoxic disorders of organophosphorus compounds and their managements.
    Balali-Mood M; Balali-Mood K
    Arch Iran Med; 2008 Jan; 11(1):65-89. PubMed ID: 18154426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicokinetics of tabun enantiomers in anaesthetized swine after intravenous tabun administration.
    Tenberken O; Mikler J; Hill I; Weatherby K; Thiermann H; Worek F; Reiter G
    Toxicol Lett; 2010 Oct; 198(2):177-81. PubMed ID: 20599598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors of organophosphate poisoning between the death and survival groups.
    Lin TJ; Jiang DD; Chan HM; Hung DZ; Li HP
    Kaohsiung J Med Sci; 2007 Apr; 23(4):176-82. PubMed ID: 17395565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme-linked immunosorbent assay for detection of organophosphorylated butyrylcholinesterase: a biomarker of exposure to organophosphate agents.
    Wang L; Du D; Lu D; Lin CT; Smith JN; Timchalk C; Liu F; Wang J; Lin Y
    Anal Chim Acta; 2011 May; 693(1-2):1-6. PubMed ID: 21504805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verification of exposure to organophosphates: Generic mass spectrometric method for detection of human butyrylcholinesterase adducts.
    Noort D; Fidder A; van der Schans MJ; Hulst AG
    Anal Chem; 2006 Sep; 78(18):6640-4. PubMed ID: 16970345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of neuromuscular transmission in organophosphate pesticide-poisoned patients.
    Thiermann H; Zilker T; Eyer F; Felgenhauer N; Eyer P; Worek F
    Toxicol Lett; 2009 Dec; 191(2-3):297-304. PubMed ID: 19793545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fast affinity purification coupled with mass spectrometry for identifying organophosphate labeled plasma butyrylcholinesterase.
    Li H; Tong L; Schopfer LM; Masson P; Lockridge O
    Chem Biol Interact; 2008 Sep; 175(1-3):68-72. PubMed ID: 18586231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrapolating from animal studies to the efficacy in humans of a pretreatment combination against organophosphate poisoning.
    Levy A; Cohen G; Gilat E; Kapon J; Dachir S; Abraham S; Herskovitz M; Teitelbaum Z; Raveh L
    Arch Toxicol; 2007 May; 81(5):353-9. PubMed ID: 17009047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.